Article

Real-world Outcomes of Diffuse Large B-cell Lymphoma Treated with frontline R-CHOP(-like) regimens in an Asian Multi-ethnic Population

2024-09-11

Abstract excerpt

<title>Abstract</title> <p>Background Recent breakthrough advances in the treatment of DLBCL, such as the antibody-drug conjugate Polatuzumab vedotin, have yielded clinical survival benefit over R-CHOP for the first time in 20 years since the advent of the Rituximab era. We thus examine the outcomes of standard immunochemotherapy for DLBCL in our multi-ethnic Asian population, so as to determine the real-world c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3183c4b-9b23-5c10-b349-28604e743877
DOI: 10.21203/rs.3.rs-4855200/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-world Outcomes of Diffuse Large B-cell Lymphoma Treated with frontline R-CHOP(-like) regimens in an Asian Multi-ethnic PopulationDOI 10.21203/rs.3.rs-4855200/v1Read

Comparative Effectiveness of CAR T-Cell Therapy versus Blinatumomab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A prospective cohort studySemantic proximity Read

Clinicopathological features and prognostic factors of rare primary bone marrow diffuse large B cell lymphomaSemantic proximity Read

[Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity].Semantic proximity Read

Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma.Semantic proximity Read

Diffuse large B-cell lymphoma.Semantic proximity Read

[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma].Semantic proximity Read

Diffuse large B-cell lymphoma: current standard treatment and future perspectives.Semantic proximity Read

[Characteristics and survival analysis of 60 cases of primary diffuse large B-cell lymphoma of the breast].Semantic proximity Read

Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases.Semantic proximity Read

Novel therapeutic targets in diffuse large B-cell lymphomaSemantic proximity Read

Are We Ready To Stratify Treatment for Diffuse Large B-Cell Lymphoma Using Molecular Hallmarks?Semantic proximity Read

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity Read